Powered by

Powered by Portfolio Grader

Supernus Pharm (SUPN)

36.63 1.03 (2.73%) 17:48 EST
SUPN Stock Quote Delayed 15 Minutes

  • SUPN Stock Chart

  • Historical SUPN Prices

  
Dividend & Yield:       N/A (N/A)
P/E:       26.54
Market Cap:       1.90B
EPS:       1.38
Volume:       383,100
Day's Range:       36.50 - 37.98
52wk Range:       30.05 - 61.25
Quotes delayed at least 20 mins.
Historical Data for SUPN
Month:  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Year:  2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Range:  1 Month 3 Month 1 Year
Date Open High Low Volume Close Change %
02/21/19 37.73 37.98 36.50 383,123 36.63 -1.03   -2.73%
02/20/19 38.10 38.51 37.30 512,131 37.66 -0.43   -1.13%
02/19/19 39.03 39.20 37.96 475,143 38.09 -1.01   -2.58%
02/15/19 38.55 39.40 38.30 860,300 39.10 0.86   2.25%
02/14/19 37.89 38.34 37.62 419,186 38.24 0.35   0.92%
02/13/19 38.36 38.73 37.22 477,384 37.89 -0.35   -0.92%
02/12/19 37.66 38.50 37.35 339,181 38.24 0.77   2.05%
02/11/19 37.76 38.35 37.12 398,520 37.47 0.02   0.05%
02/08/19 37.62 37.62 36.98 257,900 37.45 -0.37   -0.98%
02/07/19 38.25 38.50 37.29 273,078 37.82 -0.56   -1.46%
02/06/19 38.32 38.92 37.83 295,110 38.38 0.19   0.50%
02/05/19 36.89 39.16 36.63 772,526 38.19 1.31   3.55%
02/04/19 37.79 37.87 36.59 683,254 36.88 -0.81   -2.15%
02/01/19 38.00 38.00 35.89 867,400 37.69 -0.44   -1.15%
01/31/19 37.42 38.58 37.25 490,845 38.13 1.03   2.78%
01/30/19 36.79 37.97 36.29 471,644 37.10 0.34   0.92%
01/29/19 36.45 37.04 35.70 426,257 36.76 0.61   1.69%
01/28/19 36.30 36.33 35.25 670,487 36.15 -0.19   -0.52%
01/25/19 36.35 36.49 35.47 566,800 36.34 0.26   0.72%
01/24/19 37.01 37.10 35.81 433,387 36.08 -0.92   -2.49%
01/23/19 37.91 38.40 36.52 483,931 37.00 -0.62   -1.65%
01/22/19 37.97 38.15 36.87 513,576 37.62 -0.43   -1.13%
01/18/19 37.17 38.07 36.37 481,800 38.05 0.89   2.40%
01/17/19 37.43 38.09 36.77 507,555 37.16 -0.26   -0.69%
01/16/19 37.85 38.32 36.36 588,997 37.42 -0.41   -1.08%
01/15/19 37.12 38.21 36.50 489,354 37.83 0.92   2.49%
01/14/19 37.42 37.86 36.65 515,348 36.91 -0.81   -2.15%
01/11/19 35.94 38.00 35.80 624,500 37.72 1.77   4.92%
01/10/19 35.90 36.54 35.29 359,141 35.95 -0.01   -0.03%
01/09/19 35.49 36.61 34.96 689,836 35.96 0.57   1.61%
01/08/19 35.21 35.66 34.36 624,398 35.39 0.49   1.40%
01/07/19 34.48 35.99 33.76 612,058 34.90 0.56   1.63%
01/04/19 32.98 34.85 32.60 507,600 34.34 1.54   4.70%
01/03/19 32.72 34.00 32.29 554,402 32.80 0.03   0.09%
01/02/19 32.60 33.18 32.24 433,945 32.77 -0.45   -1.35%
12/31/18 32.72 33.25 32.12 391,700 33.22 0.86   2.66%
12/28/18 32.67 33.00 31.86 437,100 32.36 -0.21   -0.64%
12/27/18 31.89 32.65 31.00 416,277 32.57 0.20   0.62%
12/26/18 30.87 32.45 30.51 523,468 32.37 1.53   4.96%
12/24/18 30.77 31.66 30.05 368,800 30.84 -0.16   -0.52%
12/21/18 32.84 33.03 30.92 1,064,400 31.00 -1.85   -5.63%
12/20/18 33.22 34.75 31.89 793,093 32.85 -0.50   -1.50%
12/19/18 35.20 35.93 33.19 589,471 33.35 -1.65   -4.71%
12/18/18 36.10 36.84 34.71 827,488 35.00 -0.82   -2.29%
12/17/18 36.00 37.65 35.43 719,625 35.82 0.06   0.17%
12/14/18 35.40 37.27 35.16 1,020,500 35.76 0.16   0.45%
12/13/18 37.18 37.46 35.53 584,598 35.60 -1.60   -4.30%
12/12/18 37.98 38.00 37.06 445,337 37.20 0.22   0.59%
12/11/18 38.15 38.80 36.66 813,080 36.98 -0.93   -2.45%
12/10/18 37.34 38.41 36.47 941,555 37.91 1.38   3.78%
12/07/18 40.67 40.96 36.00 1,788,600 36.53 -4.01   -9.89%
12/06/18 40.00 40.93 38.75 2,278,384 40.54 -5.47   -11.89%
12/04/18 48.49 49.23 45.97 862,200 46.01 -2.85   -5.83%
Download Data To Spreadsheet
Supernus Pharm (SUPN) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Supernus Pharm Stock Analysis

Rating: Buy

Total Grade: B

Analysis Breakdown

SUPN Stock Grade: B
Fundamental Grade: B
Quantitative Grade: C
SUPN Earnings
Earnings Growth: B
Earnings Momentum: C
Earnings Surprises: A
Analyst Earnings Revisions: B
SUPN Financial Information
Sales Growth: A
Operating Margin Growth: B
Cash Flow: B
Return on Equity: A

Supernus Pharm Stock: Weekly View

This Week: B
Last Week: B
Two Weeks Ago: C
Get Full Report